The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
CD44 Interaction with Tiam1 Promotes Rac1 Signaling and Hyaluronic Acid-mediated Breast Tumor Cell Migration
Open accessAbstract
In this study we have explored the interaction between CD44 (the hyaluronic acid (HA)-binding receptor) and Tiam1 (a guanine nucleotide exchange factor) in metastatic breast tumor cells (SP1 cell line). Immunoprecipitation and immunoblot analyses indicate that both the CD44v3 isoform and the Tiam1 protein are expressed in SP1 cells and that these two proteins are physically associated as a complex in vivo. Using an Escherichia coli-derived calmodulin-binding peptide-tagged Tiam1 fragment (i.e. the NH(2)-terminal pleckstrin homology (PHn) domain and an adjacent protein interaction domain designated as PHn-CC-Ex, amino acids 393-738 of Tiam1) and an in vitro binding assay, we have detected a specific binding interaction between the Tiam1 PHn-CC-Ex domain and CD44. Scatchard plot analysis indicates that there is a single high affinity CD44 binding site in the PHn-CC-Ex domain of Tiam1 with an apparent dissociation constant (K(d)) of 0.2 nM, which is comparable with CD44 binding (K(d) = approximately 0.13 nM) to intact Tiam1. These findings suggest that the PHn-CC-Ex domain is the primary Tiam1-binding region for CD44. Most importantly, the binding of HA to CD44v3 of SP1 cells stimulates Tiam1-catalyzed Rac1 signaling and cytoskeleton-mediated tumor cell migration. Transfection of SP1 cells with Tiam1cDNA promotes Tiam1 association with CD44v3 and up-regulates Rac1 signaling as well as HA/CD44v3-mediated breast tumor cell migration. Co-transfection of SP1 cells with PHn-CC-Ex cDNA and Tiam1 cDNA effectively inhibits Tiam1 association with CD44 and efficiently blocks tumor behaviors. Taken together, we believe that the linkage between CD44v3 isoform and the PHn-CC-EX domain of Tiam1 is required for HA stimulated Rac1 signaling and cytoskeleton-mediated tumor cell migration during breast cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rho GTPases and the Actin Cytoskeleton
Hall, A. (1998) · Science · doi:10.1126/science.279.5350.509 · Cited by 6,140
Ridley, A. J., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90163-7 · Cited by 4,468
Nobes, C. D., & Hall, A. (1995) · Cell · doi:10.1016/0092-8674(95)90370-4 · Cited by 4,412
Cell Migration: A Physically Integrated Molecular Process
Lauffenburger, D. A., & Horwitz, A. F. (1996) · Cell · doi:10.1016/s0092-8674(00)81280-5 · Cited by 3,915
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90164-8 · Cited by 3,652
A brain serine/threonine protein kinase activated by Cdc42 and Rac1
Manser, E., Leung, T., Salihuddin, H., Zhao, Z.-S., & Lim, L. (1994) · Nature · doi:10.1038/367040a0 · Cited by 1,538
Minden, A., Lin, A., Claret, F.-X., Abo, A., & Karin, M. (1995) · Cell · doi:10.1016/s0092-8674(05)80019-4 · Cited by 1,478
The small GTP-binding proteins Rac1 and Cdc42regulate the activity of the JNK/SAPK signaling pathway
Coso, O. A., Chiariello, M., Yu, J.-C., Teramoto, H., Crespo, P., Xu, N., Miki, T., & Silvio Gutkind, J. (1995) · Cell · doi:10.1016/s0092-8674(05)80018-2 · Cited by 1,397
CD44 and Its Interaction with Extracellular Matrix
Lesley, J., Hyman, R., & Kincade, P. W. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60537-4 · Cited by 1,059
Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U., & Bell, J. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12160 · Cited by 1,015
Cited by
Extracellular matrix structure
Theocharis, A. D., Skandalis, S. S., Gialeli, C., & Karamanos, N. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.001 · Cited by 2,598
“translational modifications of CD44 proteins that result in the predominance of CD44 variant isoforms leading to increased tumorigenicity [338-346].”
BackgroundCD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,386
Guanine nucleotide exchange factors for Rho GTPases: turning on the switch
Schmidt, A., & Hall, A. (2002) · Genes & Development · doi:10.1101/gad.1003302 · Cited by 1,241
Signaling Properties of Hyaluronan Receptors
Turley, E. A., Noble, P. W., & Bourguignon, L. Y. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100038200 · Cited by 1,041
Self-citationThe role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis
Cardone, R. A., Casavola, V., & Reshkin, S. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1713 · Cited by 897
Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration
Kajita, M., Itoh, Y., Chiba, T., Mori, H., Okada, A., Kinoh, H., & Seiki, M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.893 · Cited by 746
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
Yingchoncharoen, P., Kalinowski, D. S., & Richardson, D. R. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012070 · Cited by 744
Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo
Gavin, M. A., Clarke, S. R., Negrou, E., Gallegos, A., & Rudensky, A. (2002) · Nature Immunology · doi:10.1038/ni743 · Cited by 640
Carbon nanotubes for delivery of small molecule drugs
Wong, B. S., Yoong, S. L., Jagusiak, A., Panczyk, T., Ho, H. K., Ang, W. H., & Pastorin, G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.005 · Cited by 585
Hyaluronan-binding Proteins: Tying Up the Giant
Day, A. J., & Prestwich, G. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100036200 · Cited by 567
Rho GTPases: Signaling, Migration, and Invasion
Schmitz, A. A. P., Govek, E.-E., Böttner, B., & Van Aelst, L. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.5049 · Cited by 578
Toole, B. P. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0244 · Cited by 570
Naor, D., Nedvetzki, S., Golan, I., Melnik, L., & Faitelson, Y. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795574 · Cited by 557
Morrison, H., Sherman, L. S., Legg, J., Banine, F., Isacke, C., Haipek, C. A., Gutmann, D. H., Ponta, H., & Herrlich, P. (2001) · Genes & Development · doi:10.1101/gad.189601 · Cited by 536
Hyaluronan: a multifunctional, megaDalton, stealth molecule
Lee, J. Y., & Spicer, A. P. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00135-6 · Cited by 525
Hyaluronan–CD44 interactions as potential targets for cancer therapy
Misra, S., Heldin, P., Hascall, V. C., Karamanos, N. K., Skandalis, S. S., Markwald, R. R., & Ghatak, S. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08071.x · Cited by 494
A crucial role for CD44 in inflammation
Puré, E., & Cuff, C. A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)01963-3 · Cited by 472
Role of Merlin/NF2 inactivation in tumor biology
Petrilli, A. M., & Fernández-Valle, C. (2016) · Oncogene · doi:10.1038/onc.2015.125 · Cited by 458
Platt, V. M., & Szoka, F. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800024g · Cited by 456
Bourguignon, L. Y. W., Peyrollier, K., Xia, W., & Gilad, E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800109200 · Cited by 442
Self-citationCD44 in Cancer Progression: Adhesion, Migration and Growth Regulation
Marhaba, R., & Zöller, M. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032354.94213.69 · Cited by 438
Rho-family GTPases in cadherin-mediated cell — cell adhesion
Fukata, M., & Kaibuchi, K. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35103068 · Cited by 438
Bourguignon, L. Y. W., Singleton, P. A., Diedrich, F., Stern, R., & Gilad, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311838200 · Cited by 422
Self-citationCook, D. R., Rossman, K. L., & Der, C. J. (2014) · Oncogene · doi:10.1038/onc.2013.362 · Cited by 378
Herrera, M. B., Bussolati, B., Bruno, S., Morando, L., Mauriello-Romanazzi, G., Sanavio, F., Stamenkovic, I., Biancone, L., & Camussi, G. (2007) · Kidney International · doi:10.1038/sj.ki.5002334 · Cited by 378
The Nf2 Tumor Suppressor, Merlin, Functions in Rac-Dependent Signaling
Shaw, R. J., Paez, J. G., Curto, M., Yaktine, A., Pruitt, W. M., Saotome, I., O'Bryan, J. P., Gupta, V., Ratner, N., Der, C. J., et al. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00009-0 · Cited by 343
Dbl family guanine nucleotide exchange factors
Zheng, Y. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01973-9 · Cited by 339
Ananthanarayanan, B., Kim, Y., & Kumar, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.005 · Cited by 337
Bourguignon, L. Y. W. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.007 · Cited by 305
Self-citationItano, N., Atsumi, F., Sawai, T., Yamada, Y., Miyaishi, O., Senga, T., Hamaguchi, M., & Kimata, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052026799 · Cited by 298
Nagano, O., Murakami, D., Hartmann, D., de Strooper, B., Saftig, P., Iwatsubo, T., Nakajima, M., Shinohara, M., & Saya, H. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200310024 · Cited by 294
Recruitment and activation of Rac1 by the formation of E-cadherin-mediated cell-cell adhesion sites
Nakagawa, M., Fukata, M., Yamaga, M., Itoh, N., & Kaibuchi, K. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.10.1829 · Cited by 289
Bacterial protein toxins that modify host regulatory GTPases
Aktories, K. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2592 · Cited by 288
Integrins regulate GTP-Rac localized effector interactions through dissociation of Rho-GDI
Del Pozo, M. A., Kiosses, W. B., Alderson, N. B., Meller, N., Hahn, K. M., & Schwartz, M. A. (2002) · Nature Cell Biology · doi:10.1038/ncb759 · Cited by 287
Chitosan-based nanoparticles for tumor-targeted drug delivery
Prabaharan, M. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.10.052 · Cited by 286
Singleton, P. A., Dudek, S. M., Chiang, E. T., & Garcia, J. G. N. (2005) · The FASEB Journal · doi:10.1096/fj.05-3928com · Cited by 284
Rho GTPases in transformation and metastasis
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)84003-9 · Cited by 275
Understanding the Dual Nature of CD44 in Breast Cancer Progression
Louderbough, J. M. V., & Schroeder, J. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0156 · Cited by 273
Bourguignon, L. W., Zhu, H., Shao, L., & Chen, Y.-W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006498200 · Cited by 262
Self-citationJain, A., Jain, S. K., Ganesh, N., Barve, J., & Beg, A. M. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.03.002 · Cited by 214
Emerging Roles for Hyaluronidase in Cancer Metastasis and Therapy
(2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-800092-2.00001-0 · Cited by 204
“…multiple mechanisms, involving both cytoskeletal reorganization upon direct binding of HA to surface receptors such as CD44 (Aruffo et al., 1990; Bourguignon et al., 2000; Legg et al., 2002), and receptor-mediated internalization of HA-bound complexes through endosomal pathways (Harada and…”
Rho family GTPases: more than simple switches
Symons, M., & Settleman, J. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01832-8 · Cited by 195
Chang, Q., Qin, R., Huang, T., Gao, J., & Feng, Y. (2006) · Pancreas · doi:10.1097/00006676-200604000-00010 · Cited by 57
Optimization of chitosan nanoparticles for colon tumors using experimental design methodology
Jain, A., & Jain, S. K. (2016) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.3109/21691401.2015.1111236 · Cited by 30
Hart, S. P., Rossi, A. G., Haslett, C., & Dransfield, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033142 · Cited by 24
Liang, Y., Wang, S., & Zhang, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.9077 · Cited by 22
Metadata
- Authors
- Bourguignon, L. Y. W., Zhu, H., Shao, L., & Chen, Y. W.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-01
- Volume
- 275
- Issue
- 3
- Pages
- 1829-1838
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2014226393
- Cited by
- 283
- References
- 64
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.